GRIN2D and Alzheimer disease: The same expression profile, i.e., a predicted decrease of GRIN2D and ZSWIM9 levels but increased SLC17A7 levels, was also associated with increased risk for AD, lower educational attainment, lower cognitive ability, and higher risk of major depressive disorder across several independent studies (Additional file 1: Table S10).